Flerie makes its way to the stock market via InDex

The chess pieces have long been in place for Flerie Invest, and now the specialist investor will enter the stock market through reverse acquisition by InDex Pharmaceuticals.

– This is an important step in our plan to create a new model for life science investments, says Flerie CEO Ted Fjällman.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/05/flerie-makes-its-way-to-the-stock-market-via-index/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se